Arbs expect Novartis to disrupt Noven deal (Dealscape

Shares of Noven Pharmaceuticals Inc. traded over their value in the newly launched merger with Japan's Hisamitsu Pharmaceutical Co. on speculation that Novartis AG might disrupt the $430 million deal.

Noven and Hisamitsu announced a deal Tuesday, July 14, whereby the Japanese pharmaceutical company would acquire Noven for $16.50 in cash through a tender offer. Hisamitsu is required under the agreement to launch the offer by July 28. The initial expiration date of the offer would be roughly Aug. 24.

This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence.

Dig deeper, with Pipeline.

827 in-depth reports of M&A deals in the Healthcare sector
593 company pages related to Pharmaceuticals
114 in-depth transaction records for Novartis
12 articles related to Noven Pharmaceuticals Inc.
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Deutsche Bank
Skadden Arps
Pinnacle Foods
Concho Resources
Agrium Inc.
Birds Eye
Cantor Fitzgerald
Credit Suisse
Windstream Corp.
Goldman Sachs

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? Arbs expect Novartis to disrupt Noven deal Posted on July 15, 2009 10:00 PM Shares of Noven Pharmaceuticals Inc. traded over their value in the newly launched merger with Japan's Hisamitsu Pharmaceutical Co. on speculation that Novartis AG might disrupt the $430 million deal. Noven and Hisamitsu announced a deal Tuesday, July 14, whereby the Japanese pharmaceutical company would acquire Noven for $16.50 in cash through a tender offer. Hisamitsu is required under the agreement to launch the offer by July 28. The initial expiration date of the offer would be roughly Aug. 24. This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence. Dig deeper, with Pipeline. 827 in-depth reports of M&A deals in the Healthcare sector 593 company pages related to Pharmaceuticals 114 in-depth transaction records for Novartis 12 articles related to Noven Pharmaceuticals Inc. 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Deutsche Bank Skadden Arps Pinnacle Foods Concho Resources Agrium Inc. Birds Eye Cantor Fitzgerald Credit Suisse Windstream Corp. Goldman Sachs		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.